Search Results

Downstream regulator TANK binds to the CD40 recognition site on TRAF3.

• Authors : Li C; Cancer Research Center, The Burnham Institute, La Jolla, California 92037, USA.; Ni CZ

Subjects: Adaptor Proteins, Signal Transducing* ; Protein Structure, Quaternary*; CD40 Ligand/CD40 Ligand/CD40 Ligand/*metabolism

• Source: Structure (London, England : 1993) [Structure] 2002 Mar; Vol. 10 (3), pp. 403-11.Publisher: Cell Press Country of Publication: United States NLM ID: 101087697 Publication Model: Print Cited Medium: Print ISSN: 0969-2126

Record details

The role of CD154 (CD40-ligand) in costimulation.

• Authors : Lederman S; Laboratory of Molecular Immunology, Columbia University, New York, New York, USA.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antigen-Presenting Cells/Antigen-Presenting Cells/Antigen-Presenting Cells/*immunology ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*immunology

• Source: Transplantation proceedings [Transplant Proc] 2001 Feb-Mar; Vol. 33 (1-2), pp. 202-6.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 0243532 Publication Model: Print Cited Medium: Print ISSN:

Record details

Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.

• Authors : Brook MO; Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, United Kingdom.; Jones ND

Subjects: Transplantation Tolerance*; Antigens, Differentiation, T-Lymphocyte/Antigens, Differentiation, T-Lymphocyte/Antigens, Differentiation, T-Lymphocyte/*therapeutic use ; CD40 Antigens/CD40 Antigens/CD40 Antigens/*immunology

• Source: Transplantation [Transplantation] 2005 Jul 27; Vol. 80 (2), pp. 253-4.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print Cited Medium: Print ISSN:

Record details

Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.

• Authors : Guillonneau C; Institut National de la Santé et de la Recherche Médicale, Unit 643, and Institut de Transplantation et de Recherche en Transplantation, Nantes, France.; Aubry V

Subjects: Transplantation Tolerance*; Antigens, Differentiation, T-Lymphocyte/Antigens, Differentiation, T-Lymphocyte/Antigens, Differentiation, T-Lymphocyte/*therapeutic use ; CD40 Antigens/CD40 Antigens/CD40 Antigens/*immunology

• Source: Transplantation [Transplantation] 2005 Jul 27; Vol. 80 (2), pp. 255-63.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print Cited Medium: Print ISSN:

Record details

Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.

• Authors : Gao W; Department of Medicine, Harvard Medical School, Division of Immunology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.; Demirci G

Subjects: Antigens, Surface*; CD40 Ligand/CD40 Ligand/CD40 Ligand/*immunology ; Graft Survival/Graft Survival/Graft Survival/*immunology

• Source: Transplantation [Transplantation] 2003 Sep 27; Vol. 76 (6), pp. 994-9.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print Cited Medium: Print ISSN:

Record details

A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis.

• Authors : Longo CR; Immunobiology Research Center, Department of Surgery and Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA.; Arvelo MB

Subjects: Apoptosis*; CD40 Antigens/CD40 Antigens/CD40 Antigens/*metabolism ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*pharmacology

• Source: Circulation [Circulation] 2003 Sep 02; Vol. 108 (9), pp. 1113-8. Date of Electronic Publication: 2003 Jul 28.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

Distinct contributions of different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and IL-12 secretion.

• Authors : Mackey MF; Lymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive MSC-1892, Bethesda, MD 20892-1892, USA. ; Wang Z

Subjects: CD40 Antigens/CD40 Antigens/CD40 Antigens/*physiology ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*physiology ; Carrier Proteins/Carrier Proteins/Carrier Proteins/*physiology

• Source: European journal of immunology [Eur J Immunol] 2003 Mar; Vol. 33 (3), pp. 779-89.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print Cited Medium: Print ISSN: 0014-2980 (Print)

Record details

Direct and indirect RANK ligand and CD40 ligand signaling regulate the maintenance of thymic epithelial cell frequency and properties in the adult thymus.

• Source: Health & Medicine Week; 11/1/2024, p1729-1729, 1p

Record details

Study Findings on Acute Coronary Syndrome Reported by a Researcher at Damascus University (Investigating soluble CD40 ligand as a prognostic factor among acute coronary syndromes patients: A multi-center prospective case-control study).

• Source: Heart Disease Weekly; 10/14/2024, p1213-1213, 1p

Record details

Investigators at Duke University Report Findings in Tumor Necrosis Factors (Cd40 Ligand Antagonist Dazodalibep In Sjogren's Disease: a Randomized, Double-blinded, Placebo-controlled, Phase 2 Trial).

• Source: Medical Letter on the CDC & FDA; 7/19/2024, p887-887, 1p

Record details